Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Upside appoints leading US life sciences executive to Board

August 23, 2017. AUCKLAND, NEW ZEALAND

MEDIA RELEASE

Upside Biotechnologies appoints leading US life sciences executive to Board

Regenerative medicine start-up, Upside Biotechnologies, has appointed Boston-based Dr Daniel R. Marshak Ph.D. to its Board.

New Zealand-based Upside is developing an advanced, world-class skin replacement treatment for patients suffering major burns.

Dr Marshak is an experienced senior executive in the life sciences, diagnostics, and biopharmaceutical industries, leading high-technology, global businesses and R&D functions for more than twenty years.

Currently, Dr Marshak is a consultant to several biotechnology and life sciences companies, as well as financial firms, including Ferghana Partners Group and 5AM Ventures.

He previously served as senior vice-president and chief scientific officer for PerkinElmer Inc. (NYSE:PKI) from 2006-2014. Prior to joining PerkinElmer, Dr. Marshak was vice-president and chief technology officer, biotechnology, for Cambrex Corporation (NYSE:CBM.) In that role, he helped build and manage the BioScience business unit through significant organic growth, including the first contract manufacturing of cell therapy products and other biologics.

Upside’s chief executive officer Dr Robert Feldman says he is absolutely delighted that Dan has joined the Upside Board.

“He brings exceptional sector experience, broad networks, relevant scientific knowledge, enthusiasm and dedication. In my dealings, I’ve found that many people in the field know Dan and every individual, without exception, is complimentary about Dan. Upside Biotechnologies is a stronger company thanks to Dan’s involvement,” he says.

Dr Marshak says he has been interested in regenerative medicine and tissue engineering for more than 25 years. Rapid, autologous skin regeneration for therapeutic use in wound repair has been a goal in this field for many years.

“The scientists at Upside Biotechnologies have combined optimized cell expansion, innovative matrix materials, and a unique device to generate a skin product that can revolutionize the clinical treatment of critical burns,” comments Dr Marshak.

“Upside truly epitomizes the intersection of science, engineering, and medicine to improve human health globally. I am delighted to join the team at Upside as an independent Director of the Board.”

In May 2017, Upside announced it had signed a CRADA (Cooperative Research and Development Agreement) with the U.S. Army Medical Research and Materiel Command (USAMRMC) based in Fort Detrick, Maryland.

The CRADA initiates a collaboration between the two organizations on both the scientific and regulatory aspects of Upside’s engineered skin product development.

Ends


© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 




Air New Zealand: Employees Recognised With $1,000 Share Award

The efforts Air New Zealand employees made during one of the airline’s toughest years will be recognised via an award of $1,000 worth of company shares to all permanent employees... More>>

Consumer NZ: Bank Complaints On The Rise, Survey Shows

Nearly one in five Kiwis had a problem with their bank in the past year, Consumer NZ’s latest satisfaction survey finds. Consumer NZ chief executive Jon Duffy said the number of bank customers reporting problems had jumped to 18%, up from 11% in 2020... More>>

Federated Farmers: Applauds UK-Australia Free Trade Deal

News that Australia and the UK have signed a free trade agreement is a promising step forward in the fight against tariffs and protectionism, Federated Farmers says.
"It reinforces the international rules-based trading framework and is important for rural producers and global consumers," Feds President Andrew Hoggard says... More>>




ASB: New Zealanders Missing Out On Hundreds Of Millions In KiwiSaver Government Contributions

New Zealanders have just over a week to ensure they’re eligible for the maximum annual government KiwiSaver contribution... More>>


Stats NZ: GDP Climbs 1.6 Percent In March 2021 Quarter Following December Dip

Gross domestic product (GDP) rose by 1.6 percent in the March 2021 quarter, following a 1.0 percent fall in the December 2020 quarter, Stats NZ said today. "After an easing of economic activity in the December quarter, we’ve seen broad-based growth in the first quarter of 2021... More>>

Reserve Bank: Debt Serviceability Restrictions Added To Policy Toolkit

The Reserve Bank – Te Pūtea Matua and the Minister of Finance have agreed to update their shared Memorandum of Understanding (MoU) on macro-prudential policy and add debt serviceability restrictions to the list of potential tools available... More>>